Tag: Charmaine Lok
Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system
TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...
NEAT trial shows six times fewer post-creation interventions with endovascular than...
NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...
